Back to Trials
NCT06179498NARecruiting

Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs

University of California, San Francisco

Start Date

3/25/2024

Completion Date

6/1/2027

Summary

The Partner Navigation Intervention Study is a randomized controlled study (RCT) to assess the efficacy and mechanism of action of the first behavioral intervention to increase hepatitis C (HCV) treatment initiation among adult people who inject drugs (PWID).

Detailed Description

After an initial ramp-up phase to ensure intervention materials and protocols meet the needs of the target population and organizational setting, we will apply a stratified randomized design to enroll 250 adult PWID with recently diagnosed HCV infection ("index") and their primary injecting partner("partner") into a randomized control efficacy trial of a two-session partner navigation intervention, compared to standard of care. The primary endpoint is starting HCV treatment. Recruitment will over sample PWID between 18-30 years of age.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Self report injecting drugs in the past month * Self report a primary injecting partner (currently inject drugs together) * HCV infection identified at partnering community-based clinical site

Interventions

BEHAVIORAL

Partner Navigation Intervention

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Hepatitis C

Locations

University of California, San Francisco

San Francisco, California 94158

United States